Inventor · disambiguated record
Jasper Dingemanse
Also filed as: DINGEMANSE JASPER
10 granted patents·3 pending applications·42 citations·filing 2009–2025
86Inventor score
Files withACTELION PHARMACEUTICALS LTD6IDORSIA PHARMACEUTICALS LTD3VANDA PHARMACEUTICALS INC2ACETLION PHARMACEUTICALS LTD1BROSSARD PATRICK1
Top patents by PatentIndex Score
13 records- 0194US10220023B2Dosing regimen for a selective S1P1 receptor agonistACTELION PHARMACEUTICALS LTD·Filed 2015·Granted Mar 5, 2019·19 cites·12 claims
- 0289US8785484B2Dosing regimen for a selective S1P1 receptor agonistBROSSARD PATRICK·Filed 2009·Granted Jul 22, 2014·19 cites·10 claims
- 0386US11390615B2Crystalline form of the compound (S)-3-{4-[5-(2-cyclopentyl-6-methoxy-pyridin-4-yl)-[1,2,4]oxadiazol-3-yl]-2-ethyl-6-methyl-phenoxIDORSIA PHARMACEUTICALS LTD·Filed 2020·Granted Jul 19, 2022·1 cites·19 claims
- 0485US10836754B2Crystalline form of the compound (S)-3-{4-[5-(2-cyclopentyl-6-methoxy-pyridin-4-yl)-[1,2,4]oxadiazol-3-yl]-2-ethyl-6-methyl-phenoxy}-propane-1,2-diolIDORSIA PHARMACEUTICALS LTD·Filed 2019·Granted Nov 17, 2020·1 cites·33 claims
- 0581US12336980B2Dosing regimen for a selective S1P1 receptor agonistVANDA PHARMACEUTICALS INC·Filed 2022·Granted Jun 24, 2025·0 cites·3 claims
- 0681US2025281463A1Dosing regimen for a selective s1p1 receptor agonistVANDA PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 0780US10251867B2Dosing regimen for a selective S1P1 receptor agonistACTELION PHARMACEUTICALS LTD·Filed 2015·Granted Apr 9, 2019·2 cites·7 claims
- 0879US11834443B2Crystalline form of the compound (s)-3-{4-[5-(2-cyclopentyl-6-methoxy-pyridin-4-yl)-[1,2,4]oxadiazol-3-yl]-2-ethyl-6-methyl-phenoxy}-propane-1,2-diolIDORSIA PHARMACEUTICALS LTD·Filed 2022·Granted Dec 5, 2023·0 cites·26 claims
- 0973US2021401811A1Dosing regimen for a selective s1p1 receptor agonistACETLION PHARMACEUTICALS LTD·Filed 2021·Application pending·0 cites
- 1072US11771683B2Dosing regimen for a selective S1P1 receptor agonistACTELION PHARMACEUTICALS LTD·Filed 2020·Granted Oct 3, 2023·0 cites·15 claims
- 1171US10660880B2Dosing regimen for a selective S1P1 agonistACTELION PHARMACEUTICALS LTD·Filed 2014·Granted May 26, 2020·0 cites·4 claims
- 1265US10857134B2Dosing regimen for a selective S1P1 receptor agonistACTELION PHARMACEUTICALS LTD·Filed 2019·Granted Dec 8, 2020·0 cites·8 claims
- 1362US2014303217A1Dosing regimen for a selective s1p1 receptor agonistACTELION PHARMACEUTICALS LTD·Filed 2014·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jasper Dingemanse files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →